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Summary The oncogenicity of Duck hepatitis B virus (DHBV) is unclear since hepatocellular carcinomas
(HCCs) have been reported only in domestic ducks in Qidong, an area of China where hepatitis B virus (HBV)
and aflatoxin B1 (AFB,) are risk factors for liver cancer in man. In order to better define the association
between DHBV infection, AFB, and HCC we analysed a series of 16 duck liver samples collected from local
farms in Qidong. HCC was found in eight and cirrhosis in one of these samples. Furthermore bile duct
proliferation, characteristic of AFBI exposure in ducks and other animal species, was found in these ducks.
Integration of DHBV DNA into cellular DNA was observed in only one out of four DHBV positive HCCs,
indicating that viral integration is not prerequisite for tumour development. In four remaining HCCs the
polymerase chain reaction (PCR) failed to show any DHBV DNA suggesting that liver tumours do occur in
these ducks in the absence of DHBV infection. In addition, AFB,-DNA adducts were detected by hplc-
immunoassay in one such DHBV-negative tumour. In summary we demonstrate that risk factors other than
DHBV, including AFB, exposure, may be important in duck liver carcinogenesis in Qidong.
All members of the hepadnavirus family, which includes
hepatitis B viruses isolated from human (HBV), woodchucks
(WHV), ground squirrels (GSHV) herons (HHV) and ducks
(DHBV), share the ability to establish persistent infection in
their hosts, are predominantly hepatotropic and have a
relatively narrow host range, although they differ in their
oncogenic potential (Schodel et al., 1989). WHV seems more
oncogenic than HBV and other known hepadnaviruses, since
100% of woodchucks experimentally infected with this virus
develop hepatocellular carcinoma (HCC) within 17-36
months after infection (Popper et al., 1987). In ground squir-
rels persistently infected with GSHV the latency is longer and
the percentage of carriers developing HCC is lower (Marion
et al., 1986). This difference in oncogenicity seems to be
related to the transforming capacity of these viruses since,
despite similar levels of virus production and similar
preneoplastic disease, WHV induces HCC more rapidly and
more frequently than GSHV in woodchuck (Seeger et al.,
1991).
By contrast to mammalian hepadnaviruses only limited
data is available on a possible association between DHBV
infection and HCC. Pekin ducks congenitally infected with
DHBV and followed for several years in various studies have
not developed liver tumours (Freiman & Cossart 1986; Cova
et al., 1990; Cullen et al., 1990; Lambert et al., 1991). In fact
HCC has been found only in domestic brown ducks from a
single area of China, Qidong and only four Chinese duck
HCCs had so far been described (Omata et al., 1983; Marion
et al., 1984; Yokosuka et al., 1985). Unlike the HCCs in
human and woodchuck in which integrated HBV and WHV
DNA in the host genome has regularly been observed
(Brechot et al., 1980, Ogston et al., 1982), only a single case
of Chinese duck HCC with integrated DHBV DNA has to
date been reported (Yokosuka et al., 1985).
Qidong is an area of high human HCC incidence in China, in
which both HBV and aflatoxin B1 (AFB1) are risk factors
(Sun et al., 1986). Ducks are highly susceptible to the car-
cinogenic effects of AFBI and have been used in our
laboratory (Cova et al., 1990) and others (Uchida et al.,
1988; Cullen et al., 1990) as an experimental system to study
the role of hepadnavirus infection and AFBI exposure in the
induction of liver tumours. The capacity of DHBV-infected
duck hepatocytes to metabolise AFBI had been also inves-
tigated in vitro (Olubuyide et al., 1991).
The high prevalence of human and duck liver cancer in
Qidong may indicate the presence of common environmental
risk factors. In the present study, in order to better define the
association between DHBV infection, AFB, and HCC, we
analysed a series of liver samples recently collected from
domestic ducks in local farms in Qidong.
Materials and methods
Liver samples
Sixteen liver samples from adult (at least 3 year old) domestic
Chinese brown ducks were collected from local farms in
Qidong (1988-1989). These samples were not randomly col-
lected, but selected for liver disease on routine pathologic
examination of ducks. All ducks were raised on human
domestic food which was predominantly corn. All samples
were sent from China to France as frozen material. No sera
were available.
Histological study ofduck livers
The frozen liver tissue was cut into small pieces, fixed in 10%
buffered formalin, embedded in paraffin and sections were
stained with standard histopathological techniques. The
histological criteria for diagnosis of liver pathology were as
follows; HCC were classified according to Nakashima and
Kojiro (1987) as trabecular (sinusoidal), schirrous (scleros-
ing), pseudoglandular (acinar) and undifferentiated types.
Portal inflammation was graded as absent, minor (+) involv-
ing few portal tracts and prominent (+ +) involving lym-
phocyte infiltrate which expanded the limiting plates and
often bridged the adjacent portal tracts and was associated
with hepatocyte necrosis. Focal parenchymal lymphocyte
infiltrates were recorded. Biliary proliferation was graded as
absent, mild (+), and prominent (+ +) the latter involving
enlargement with extension into parenchyma along with por-
tal tract enlargement. The absence of any feature suggestive
of liver disease was classified as no pathology, but could
include fatty change (steatosis) and focal hepatocyte
necrosis.
Correspondence: L. Cova, INSERM U271, 151 Cours A. Thomas,
69003 Lyon France.
Received 28 April 1993; and in revised form 9 July 1993.
Br. J. Cancer (1994), 69, 104-109 (D Macmillan Press Ltd., 1994DHBV INFECTION, AFBI AND LIVER CANCER IN DUCKS 105
Dot-blot and Southern blot analysis ofliver DNA
The liver tissue (0.2 g) was homogenised in liquid nitrogen,
incubated with proteinase K (300 tg ml-') in the presence of
0.1% sodium dodecyl sulfate at 37°C for 3 h, thereafter
proteins were removed by extraction with phenol/chloroform
and DNA was precipitated with ethanol. Screening for the
presence of DHBV DNA was performed by dot-blot hyb-
ridisation of 20 fg heat denatured liver DNA spotted in
duplicate onto nitrocellulose (Schleicher & Schuell) and hy-
bridised with radiolabelled DHBV probe as described (Cova
et al., 1990). For the Southern blot analysis, DNA samples
(15 jg) were digested with restriction endonucleases (Boeh-
ringer Mannheim), subjected to electrophoresis through 0.8%
(w/v) agarose (Sigma, USA) gel, transferred to nitrocellulose
and hybridised to DHBV DNA radiolabelled by nick transla-
tion as described previously (Lambert et al., 1990). The filters
were washed, air dried and exposed at - 70°C against Amer-
sham hyperfilm MP as described (Cova et al., 1990).
Detection ofDHBV by Polymerase Chain Reaction
Enzymatic amplification DHBV-specific primers MD03 5'-
CTCAAGCTTATCATCCATATA and MD33 5'-CTTGGA-
TCCAATGGGCGTCGGTCT located in the most conserved
region of the polymerase gene Mack & Sninsky (1988) were
used. The position of these primers in the DHBV genome
have been described by Mack & Sninsky (1988). Each reac-
tion was performed essentially as described by Saiki et al.
(1988) in a total volume of 50 Il containing the following:
10 mM Tris-HCI pH 8.4; 2 mM MgC12; 50 mM KCI; 0.01%
gelatin, 200 !LM of each dNTP, 1 tLM each primer; 1 ,tg liver
DNA; 0.5 units of Taq polymerase (Perkin-Elmer, Cetus
USA). This mixture was overlayed with 100 gil of mineral oil
and amplified for 35 cycles using a DNA thermal cycler
(Perkin-Elmer, Cetus, USA). During each cycle, samples were
heated to 94°C for 30 s, cooled to 55°C for 30 s, and
incubated for 1 min at 72°C, with a final extension step of
1Omin at 72°C.
Analysis ofamplified DNA Ten LI of the PCR product were
resolved in a 3% NiuSieve (FMC Corporation)-1% agarose
(Sigma, USA) gel and transferred on a nylon membrane
(Hybond N+, Amersham) by alkaline blotting. Ten
picomoles of the MD1O 5'-CAGCCCTTTTCTCCTCCAT-
CTCTTCACTACTGCCCTCGGA oligonucleotide probe,
specific for the amplified DHBV fragment, were labelled by
terminal transferase using (a-32P)dCTP (3000 m Ci mmol l',
Amersham) as previously described (Baginski et al., 1991).
The filters were hybridised overnight at 42°C, thereafter
excess probe was removed by several washes at 42°C as
described (Chemin et al., 1991). The filter was air-dried and
then autoradiographed at - 70°C using X-ray film
(Hyperfilm MP; Amersham). The sensitivity of this PCR-
Southern blot (PCR-SB) assay was estimated to 0.8 fg using
serial dilutions of DNA from a DHBV- positive liver (data
not shown). Each sample was tested at least three times in
this SB-PCR.
Analysis ofaflatoxin DNA adduct
Analysis was essentially performed as described previously
(Hollstein et al., 1992) with minor modification. DNA was
extracted from frozen liver tissues (1.6-2.5 g) using phenol-
chloroform and purified DNA was alkali treated to effect
imidazole ring opening of the AFB,-guanine adducts (8,9-
dihydro-8-(2,6-diamino-4-oxo-3,4-dihydro-pyrimid-5-ylform-
amido-)-9hydroxy) AFB, (AFBI-Fapy). DNA was then acid
hydrolysed (0.1 M HCI; 90°C, 20 min) to release AFB,-
imidazole ring opened guanine residues. The hydrolysed
DNA was diluted to a final volume of 30 ml with phosphate
buffered saline (pH 7.4) and loaded onto an activated Sep-
pak C18 cartridge (Waters) for clean-up of AFB,-Fapy
residues. The AFBI-Fapy containing eluate was subjected to
hplc purification by reverse phase chromatography as de-
scribed (Hollstein et al., 1992) collecting 5 min fractions.
Fractions were dried and the samples reconstituted in 250 Al
PBS with 1% foetal calf serum for ELISA. A second series of
injections using the same hplc system were made of aliquots
of hydrolysed DNA kept prior to Sep-pak purification to
determine the amount of DNA from adenine content. The
ELISA was performed as described (Hollstein et al., 1992;
Chapot & Wild 1991). As the AFB1-Fapy mainly eluted in
two hplc fractions then around 600 fmoles is required in any
sample for a positive result. The sensitivity of the assay is
therefore defined for each sample as 600 fmoles divided by
the quantity of DNA available.
Results
Occurrence andhistological characteristics ofliver tumours in
Qidong ducks
The liver pathology study indicates (Table I) that HCCs were
found in eight (nos 31, 35, 37, 39, 40, 41, 42, 44) out of 16
ducks. The predominant morphological pattern of HCC was
trabecular with tumour cells arranged in several thick cell
plates and resembling hepatocytes with eosinophilic cytop-
lasm, prominent nucleoli and which were often separated by
fibrous bands (Figure 1). The other morphological subtypes
were; schirrous (nos 41, 42) and pseudoglandular (nos 35, 39,
40) (Table I). The schirrous type was characterised by the
Figure 1 Hepatocellular carcinoma forming thick liver cell struc-
tures (duck no. 40). H&E x 250.
Table I DHBV infection and liver diseases in Qidong ducks
Associated histopathologicalfeatures
Lymphocyte Biliary
Duck DHBVd HCC infiltration proliferation
30 - - +
31 - + ++ +
32 _ _ +
33 + - ++ _
34* + _ ++ ++
35 _ b ++ +
36 - - + +
37 + + _
38 + - + _
39 _ b +
40 _ + b,c
41 + +ac
42 + +a
43 + - - -
44 + + _ _
45 - - - -
aWere scirrhous type HCC, bpseudoglandular, cundifferentiated
type. *Duck no. 34 had liver cirrhosis. dScreening of liver samples
for the presence of DHBV DNA was performed by dot-blot
hybridisation of heat-denatured liver DNA (see Materials and
methods).106 L. COVA et al.
presence of thick bands of fibrous septa, clearly seen at high
magnification (Figure 2), which had isolated groups of
tumour cells resembling hepatocytes. The pseudoglandular
type HCC showed a variety of gland like cystic spaces
formed by central degeneration or breakdown of otherwise
solid trabeculae. In some ducks (nos 37, 40, 41) the tumour
cells had a tendency towards poor differentiation along with
the presence of multinucleated or single nucleus tumour giant
cells and erythropoesis foci mostly composed of pleomorphic
clumps of erytheroid and myeloid precursors together with
megakaryocytes. Liver cirrhosis (no 34) was characterised by
well formed regenerative hyperplastic nodules separated by
fibrous septa containing periportal periseptal lymphocyte
infiltration (+ +), biliary proliferation (+ +), and occasional
hepatocyte necrosis. The other non neoplastic lesions were
lymphocyte infiltrate (+/+ +) present in eight and biliary
proliferation (Figure 3) present in four ducks. In addition,
foci of hyperplastic eosinophilic hepatocytes composed of
large cells with deeply stained cytoplasm were present. No
parasites or ground glass hepatocytes were present.
Detection ofDHBV DNA in duck livers
DHBV DNA was initially detected by a conventional blot
hybridisation test in eight out of 16 (50%) liver samples
(Table I). There were four non tumorous livers (nos 33, 34,
38, 43) and four HCCs (nos 37, 41, 42, 44) which were
DHBV positive (Table I). However, in the remaining four
HCCs (nos 31, 35, 39, 40) DHBV DNA was undetectable by
dot-blot hybridisation (Table I). PCR was performed using
DHBV specific primers to assess whether the failure of
DHBV DNA detection in these four HCCs was related to the
absence of virus in these livers or to the low level of viral
replication undetectable by dot-blot hybridisation. Agarose
gel analysis of amplification products revealed the presence
of the predicted 124 bp band in samples of liver DNA
derived from two French ducks (Figure 4a lanes 1 and 8),
known to be congenitally infected with DHBV (Cova et al.,
1990), as well as the Qidong duck no 42 (Figure 4a, lane 6)
shown by dot-blot to be DHBV-positive (Table I). These
positive results were confirmed by SB-hybridisation of the gel
with the DHBV-specific MD 10 oligonucleotide probe
(Figure 4b). None of the four Qidong duck HCCs (Figure
4a, b, lanes 2-5) which were negative for DHBV by dot blot
or a control liver sample from an uninfected French duck
(lane 7) gave a hybridisation signal with MD 10 probe.
Taken together these results suggest that liver cancer in
Qidong ducks occur in the absence of DHBV-DNA detect-
able by SB-PCR (detection limit: 0.8 fg of DHBV DNA per
ILg of liver DNA).
State ofviral DNA in HCCs
Integration of viral DNA sequences into cellular DNA is
characteristic of hepadnavirus-induced HCC. To determine
1 2 3 4 5 6 7 8 M
whether integration of DHBV DNA occurs in the liver
tumours of Qidong ducks, we examined DNA from virus-
positive HCC nos 37, 41, 42, 44. The analysis by Southern
blot of undigested liver DNA revealed the presence of a high
molecular weight band in only one (no 42) out of the four
DHBV positive HCCs (data not shown). The DNA prepared
from this tumour was further analysed by digestion with
restriction endonucleases (KpnI, XhoI, EcoRI), each having
a single recognition site in this DHBV isolate (Figure 5a, b).
The high molecular weight band observed in uncut DNA
from this HCC was converted after digestion with KpnI,
XhoI or EcoRI to several slowly migrating DNA fragments
of 5 to 11 kb size (Figure Sb), indicating that DHBV
Figure 2 Hepatocellular carcinoma schirrous type. Small groups
of tumour cells are separated by fibrous tissue (duck no. 41)
H&E x 150.
a
Figure 3 Biliary proliferation present in fibrous septa of a cirr-
hotic nodule (duck no. 34) H&E x 150.
b
1 2 3 4 5 6 7 8
124 bp
Figure 4 PCR amplification of DHBV in the duck livers. a, Ethidium bromide-stained agarose gel. b, Autoradiograph of gel in a,
Southern blotted and hybridised with DHBV specific probe MD 10. Lanes 1 and 8 liver DNA of French ducks nos 562 and 447
congenitally infected with DHBV (positive controls); lanes 2 to 6 respectively, DNAs from Qidong duck HCCs nos 31, 35, 39, 40,
42; lane 7 DNA from an uninfected French duck no 256 (negative control). Arrow indicates 124 base pairs. Lane M, Hae
III-cleaved pBR322 DNA served as a molecular weight marker.
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Figure 5 Southern blot analysis of DHBV DNAs obtained from
Qidong ducks a, Liver from duck 33 which had no hepatic
neoplasma. b, HCC from duck 42. Purified DNA was undigested
(lane 1), digested with KpnI (lane 2), XhoI (lane 3), EcoRI (lane
4). The size markers (in kilobases) are HindIll-digested lambda
DNA.
sequences were integrated into cellular DNA. As expected,
such fragments were not observed in the DNA prepared from
the non neoplastic tissue (Figure 5a).
AFB, adducts detection
DNA was extracted from eight liver samples, including seven
HCCs from Qidong. Of these HCCs the non neoplastic tissue
was available from only one sample, duck no. 31. The other
samples were from the tumorous part of the liver. AFBI-N7-
guanine is the adduct initially formed in DNA after AFB1
exposure but is either rapidly lost due to depurination (half
life; eight to 12 h) (Groopman et al., 1980) followed by
excretion in the urine or is converted to AFB,-Fapy which is
more stable and persistent. The latter adduct is the major one
in the rat 48 h after treatment (Hertzog et al., 1980) and has
been detected in duck liver after injection with (3H) AFBI
(Cova et al., 1990). In the present study DNA was alkali
treated prior to hydrolysis to convert any AFB1-N7-guanine
to AFBI-Fapy. The presence of AFB1-Fapy was detected in
one of the liver samples (no 31) (Figure 6a). The basis of this
identification is (i) the inhibition in immmunoassay using an
aflatoxin-specific antibody and (ii) the co-chromatography of
this inhibitory material with authentic AFBI-Fapy adduct
(Figure 6b). Two separate analyses of this liver were made
starting each time from a different piece of liver tissue and
both analyses were positive, the level of adducts determined
being 4.61 and 1.73 ng AFBI-Fapy per mg DNA
(mean = 3.17 ng mg-' or 6.38 pmoles per mg DNA). The
quantitative differences in the two results could reflect
differences in localisation of adducts within the liver and/or
interassay variation. It is perhaps significant that sample 31
was the only HCC sample for which non neoplastic tissue
was available. An attempt was made to measure the AFBI-
Fapy in the tumour part of the liver from the same duck but
only 0.15 mg DNA was available giving a detection limit of
around three pmoles AFBI-Fapy per mg DNA and the sam-
ple was below this limit of detection.
Discussion
There are limited data on the correlation between DHBV
infection and liver disease occurring in domestic ducks from
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Figure 6 AFB,-Fapy adducts in duck liver DNA. AFB,-Fapy
adducts were assayed as described in Materials and methods. a,
Shows the inhibition in ELISA by each hplc fraction for duck 31
(d) and a control duck from an area where dietary AFB,
exposure would be expected to be low, (0). b, Shows the same
profile for AFBI-Fapy standard injected onto the hplc under the
same conditions (A).
Qidong county since for previous studies (Marion et al.,
1984; Omata et al., 1983) only a small number ofliver tumours
was available most of them being paraffin embedded material
which considerably increased the difficulty in their molecular
analysis. We report here our investigations on liver cancer,
DHBV infection, viral DNA integration and AFB, adducts
in a panel of frozen liver samples from Qidong ducks.
In previous studies only four HCC's were described and all
of them were well differentiated HCC of trabecular type
(Omata et al., 1983; Marion et al., 1984; Yokosuka et al.,
1985). In the present study of a larger panel of eight HCCs
we have observed a range of different morphological types
e.g. schirrous, pseudoglandular and even undifferentiated
HCC. The presence of liver cirrhosis was observed by us and
by Omata et al. (1983) in Qidong ducks. Another interesting
pathological feature of our study, not previously reported,
was the biliary proliferation both in ducks with and without
HCC from the Qidong area. Biliary proliferation has not
been reported to be associated with DHBV infection but is
seen in ducks experimentally exposed to AFB1 (Uchida et al.,
1988; Cova et al., 1990; Cullen et al., 1990). While our
observations of biliary proliferation are therefore consistent
with AFB, exposure we cannot rule out that it could have
been a result of exposures to factors other than aflatoxin.
In two previous studies liver disease and HCC in ducks
from Qidong were not always associated with detectable
virus (Marion et al., 1984; Omata et al., 1983). It has been
suggested that a low level of DHBV replication might occur
in some such livers, although it was at the limit of sensitivity
of a dot blot assay. We have taken advantage of the high
a
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specificity and sensitivity of SB-PCR, which has been found
104 times more sensitive than the dot-blot assay (Chemin et
al., 1991), to search for the presence of DHBV DNA in the
Chinese duck HCCs. We demonstrated here that in four out
of eight HCCs SB-PCR failed to show any DHBV DNA,
suggesting that liver tumours occur in the ducks from
Qidong in the absence of DHBV infection. The absence of
detectable viral DNA is not due to failure of DHBV specific
primers to anneal to the DNA of the Chinese DHBV isolate
since the primer set chosen for this study, located in the
highly conserved region of hepadnavirus DNA polymerase,
permitted the amplification of DHBV DNA in infected livers
originating from both French and Qidong ducks.
The association between HBV, WHV and GSHV DNA
integration and HCC has been demonstrated as frequently
associated with malignant transformation (Brechot et al.,
1980; Ogston et al., 1982; Marion et al., 1986). The previous
reports on Chinese duck HCC revealed only a single case of
DHBV DNA integration (Yokosuka et al., 1985) and in this
study we report a second case. The integration of DHBV
DNA is not a prerequisite for HCC development since it was
observed in only one out of four DHBV-positive HCCs
analysed in the present study. The results of Cullen et al.
(1990) suggested a possible role ofAFB, in the integration of
DHBV into high molecular weight DNA. The significance of
DHBV DNA integration observed in Qidong ducks remains
to be clarified. It is of interest to note that the integrated
DHBV DNA observed by us in duck no 42 was associated
with an intense ongoing viral DNA replication. This is
similar to the woodchuck HCC, but different to most HBV-
associated human HCC in which replication of virions is
diminished or even absent (Sherker & Marion, 1991).
The exposure of domestic ducks in Qidong to AFB, has
been suggested, but never demonstrated. However, given the
high aflatoxin content of maize in Qidong (Zhu & Huang,
1986) the exposure of both humans and domestic animals
would be expected (Sun et al., 1986). In the present study one
duck (no 31) was positive for the presence of AFB,-DNA
adducts in liver. This duck had no DHBV infection and had
significant biliary proliferation, a feature of aflatoxin
exposure in ducks. As mentioned above, this was the only
sample where non neoplastic tissue was available. The lack of
detectable AFBI-DNA adducts in the other ducks could
therefore have been a result of only tumour tissue being
available for analysis or alternatively, the AFB, exposure
could have been lower in these ducks. The levels of AFB,-
Fapy have previously been measured after a single dose of
AFBI in adult ducks (Cova et al., 1990) and ducklings (Wild
et al., 1993). A single dose of 20 ,tg AFBI/kg in adult ducks
gave a mean 0.57 ± 0.12 ng AFBI-Fapy mg-' DNA and a
single dose of 2jig kg-' in ducklings gave 0.025 +
0.002 ng mg-'. The present level is therefore about five times
higher than a single dose of 20 tg kg-'. AFBI-Fapy can
accumulate upon repeated exposures in rats (Croy & Wogan,
1981) and persist up to 19 weeks post treatment (Groopman
et al., 1988) therefore the chronic dose producing this level of
DNA adduct could be much lower than 20fig kg-'. The
duck adduct level is also similar to those reported in human
liver samples from hepatocellular carcinoma patients in
Taiwan (Hsieh et al., 1988) and experimentally in rats and
trout in which HCC was induced by AFBI (Bechtel,
1989).
As only one duck was positive for AFBI-DNA adducts in
this study further investigation of food contamination and
aflatoxin-DNA adducts in duck liver are required in order to
confirm the suggested importance of this carcinogen in liver
cancer development in Qidong ducks. Since Qidong is the
only area where liver cancer has been reported in ducks the
possibly important role ofAFBI raises the question of wheth-
er DHBV is indeed an oncogenic virus or not. The differ-
ences in the oncogenicity between mammalian and avian
hepadnaviruses might be related not only to the milder liver
disease induced by DHBV in its host, but also to a direct
effect of viral gene products such as the X gene which can
transactivate cellular transforming genes (Zahm et al., 1988),
but is lacking in DHBV.
Recently, a high frequency of a mutational hotspot in
codon 249 of the p53 tumour suppressor gene was found in
human hepatomas from patients in Qidong and Southern
Africa but not in the HCCs from several geographic loca-
tions in which AFB, is not a risk factor (Bressac et al., 1991;
Hsu et al., 1991; Ozturk et al., 1991) supporting the impor-
tant role of AFB, in liver carcinogenesis in some geo-
graphical areas. This specific p53 mutation may be indepen-
dent of HBV infection (Hayward et al., 1991), although the
different mechanisms of a possible interaction between HBV
infection and exposures to AFB, in liver carcinogenesis are
important to define and have been recently discussed (Wild et
al., 1993). The ongoing search for the p53 gene mutation in
Qidong duck hepatomas will be informative in this
respect.
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